Abstract:Background & aims: Neuronal function is exquisitely sensitive to alterations in the extracellular environment. In patients with hepatic encephalopathy (HE), accumulation of metabolic waste products and noxious substances in the interstitial fluid of the brain is thought to result from liver disease and may contribute to neuronal dysfunction and cognitive impairment. This study was designed to test the hypothesis that the accumulation of these substances, such as bile acids, may result from reduced clearance from the brain. Methods: In a rat model of chronic liver disease with minimal HE (the bile duct ligation [BDL] model), we used emerging dynamic contrast-enhanced MRI and mass-spectroscopy techniques to assess the efficacy of the glymphatic system, which facilitates clearance of solutes from the brain. Immunofluorescence of aquaporin-4 (AQP4) and behavioural experiments were also performed. Results: We identified discrete brain regions (olfactory bulb, prefrontal cortex and hippocampus) of altered glymphatic clearance in BDL rats, which aligned with cognitive/behavioural deficits. Reduced AQP4 expression was observed in the olfactory bulb and prefrontal cortex in HE, which could contribute to the pathophysiological mechanisms underlying the impairment in glymphatic function in BDL rats. Conclusions: This study provides the first experimental evidence of impaired glymphatic flow in HE, potentially mediated by decreased AQP4 expression in the affected regions. Lay summary: The 'glymphatic system' is a newly discovered brain-wide pathway that facilitates clearance of various substances that accumulate in the brain due to its activity. This study evaluated whether the function of this system is altered in a model of brain dysfunction that occurs in cirrhosis. For the first time, we identified that the clearance of substances from the brain in cirrhosis is reduced because this clearance system is defective. This study proposes a new mechanism of brain dysfunction in patients with cirrhosis and provides new targets for therapy.

Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy

Microbiota-gut-liver-brain axis and hepatic encephalopathy

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

Infection, inflammation and hepatic encephalopathy from a clinical perspective

Novel Insights into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, from the Gut Microbiota Perspective

Expert Insights: The Potential Role Of The Gut Microbiome-Bile Acid-Brain Axis In The Development And Progression Of Alzheimer'S Disease And Hepatic Encephalopathy

Hepatic encephalopathy: current challenges and future prospects

S4646 The Brain-Gut-Liver Axis: A Case Study Perspective on Gut Dysbiosis and Hepatic Encephalopathy in MAFLD

Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment

The neurogliovascular unit in hepatic encephalopathy

Fecal Microbiota Transplantation for Treating Hepatic Encephalopathy: Experimental and Clinical Evidence and Possible Underlying Mechanisms

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

The assessment and management of cirrhotic patients with encephalopathy

Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective

Nonpharmacologic Management of Hepatic Encephalopathy: An Update

Effect of Probiotic Treatment on Cirrhotic Patients with Minimal Hepatic Encephalopathy: A Meta-Analysis.

Clinical science workshop: targeting the gut-liver-brain axis

Pathophysiology of hepatic encephalopathy: The concept of synergism

Impaired brain glymphatic flow in experimental hepatic encephalopathy